• Explore /
  • Poster
  • / Long-term analysis of the WHO-defined molecular subgroups of high-risk grade II gliomas treated with radiation and temozolomide on NRG Oncology/RTOG 0424.

Long-term analysis of the WHO-defined molecular subgroups of high-risk grade II gliomas treated with radiation and temozolomide on NRG Oncology/RTOG 0424.

Abstract Poster

Authors

null

Erica Hlavin Bell

The Ohio State University, Columbus, OH

Erica Hlavin Bell , Stephanie L. Pugh , Barbara Jean Fisher , Glenn Jay Lesser , David R. Macdonald , Jessica L. Fleming , Joseph P. McElroy , Aline P. Becker , C Leland Rogers , Thomas J. Doyle , Maria Werner-Wasik , Jean-Paul Bahary , Michael Yu , David D'Souza , Nadia N. Laack , Patricia Penny Sneed , Young Kwok , Steven P. Howard , Minesh P. Mehta , Arnab Chakravarti

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Discussion Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Biologic Correlates

Clinical Trial Registration Number

NCT00114140

Citation

J Clin Oncol 38: 2020 (suppl; abstr 2518)

DOI

10.1200/JCO.2020.38.15_suppl.2518

Abstract #

2518

Poster Bd #

9

Abstract Disclosures

Similar Posters

First Author: Andrew Jehyun Song

First Author: Ulrich Herrlinger

First Author: V. Verschaeve

Poster

2023 ASCO Annual Meeting

<span>Short-length DNA fragments in plasma to predict clinical outcome in unresected glioblastoma patients.</span>

Short-length DNA fragments in plasma to predict clinical outcome in unresected glioblastoma patients.

First Author: Maxime Fontanilles